Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's disease model

Sherry A Ferguson1, Sumit Sarkar, Larry C Schmued

  • 1Division of Neurotoxicology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, United States. Sherry.Ferguson@fda.hhs.gov

Summary

Longitudinal assessment of Alzheimer